Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle.
about
Caveolinopathies: from the biology of caveolin-3 to human diseasesPTRF/Cavin-1 Deficiency Causes Cardiac Dysfunction Accompanied by Cardiomyocyte Hypertrophy and Cardiac FibrosisLipid modulation of skeletal muscle mass and functionSubstrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout heartsSpatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cellsCholesterol depletion in adipocytes causes caveolae collapse concomitant with proteosomal degradation of cavin-2 in a switch-like fashionRole of caveolin-3 and glucose transporter-4 in isoflurane-induced delayed cardiac protection.Endothelial and smooth muscle cell ion channels in pulmonary vasoconstriction and vascular remodelingHigh density lipoprotein (HDL) promotes glucose uptake in adipocytes and glycogen synthesis in muscle cells.CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway.Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation.Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance.Caveolae as organizers of pharmacologically relevant signal transduction molecules.MURC/Cavin-4 and cavin family members form tissue-specific caveolar complexes.Cellular prion protein and caveolin-1 interaction in a neuronal cell line precedes Fyn/Erk 1/2 signal transduction.Fyn kinase function in lipid utilization: a new upstream regulator of AMPK activity?Cholesterol removal from adult skeletal muscle impairs excitation-contraction coupling and aging reduces caveolin-3 and alters the expression of other triadic proteins.Epigenetic modifications of caveolae associated proteins in health and disease.Essential role of caveolin-3 in adiponectin signalsome formation and adiponectin cardioprotection.Exercise training improves liver steatosis in miceGenetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration.Novel roles for insulin receptor (IR) in adipocytes and skeletal muscle cells via new and unexpected substrates.Cav1 suppresses tumor growth and metastasis in a murine model of cutaneous SCC through modulation of MAPK/AP-1 activationHeterozygous caveolin-3 mice show increased susceptibility to palmitate-induced insulin resistance.Lipid mediators in membrane rafts are important determinants of human health and disease.Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders.Maternal substrate utilization programs the development of the metabolic syndrome in male mice exposed to high fat in uteroSpatial organization of transmembrane receptor signallingFat caves: caveolae, lipid trafficking and lipid metabolism in adipocytes.Caveolins in rhabdomyosarcomaLipid rafts in immune signalling: current progress and future perspective.Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders.Sevoflurane preconditioning attenuates myocardial ischemia/reperfusion injury via caveolin-3-dependent cyclooxygenase-2 inhibitionCav1 inhibits benign skin tumor development in a two-stage carcinogenesis model by suppressing epidermal proliferation.MG53's new identity.Quasi-Steady-State Analysis based on Structural Modules and Timed Petri Net Predict System's Dynamics: The Life Cycle of the Insulin Receptor.Caveolin-3 promotes glycometabolism, growth and proliferation in muscle cells.Caveolins as regulators of stress adaptation.Sex-specific, reciprocal regulation of ERα and miR-22 controls muscle lipid metabolism in male mice.Ganglioside GM3 content in skeletal muscles is increased in type 2 but decreased in type 1 diabetes rat models: Implications of glycosphingolipid metabolism in pathophysiology of diabetes.
P2860
Q24599074-9482F88D-0340-4A97-90CC-BCB4B0AE5D89Q27322991-5F025FD9-CAED-4C9D-A2AB-A27D55637CA2Q28073878-38BEC35D-655E-4C56-9812-838687513A42Q28506400-6E0F67C9-8565-4EBA-A25F-93725E6724A0Q28506688-15F8C091-1BB1-4F9E-A7DA-A92159681484Q28730717-FC05FE79-859B-413B-9574-922999E9F615Q33814419-0CB56977-9D0D-44FD-95E9-78F77BE084CBQ33925149-897359A5-BAD0-495E-8756-68FB1EC36811Q34008856-F7D1E518-B2A8-4C0F-A9D5-A15CDB4B84F6Q34168489-A4C4DB23-ED0D-4C14-AB1D-BFD836FCBBCCQ34686759-955677DA-6778-4A8A-B5BA-23F7C0E58DA0Q34847724-8ABD1813-A38C-4CFD-86A5-4E9FCA79960BQ34877306-DFA9A5C8-3C5E-4B40-A5F3-92E36984E1F4Q34988286-69E75439-154F-44FF-BB4A-D2EDC187F6F3Q35016910-18815F16-B75B-4887-9FAD-1DE133D30C77Q35073442-802E35A1-20ED-4B72-B507-A42AFEBE59BCQ35356113-15AA6D4E-6ED9-41EB-83F9-1D753A4277E0Q35674847-51B345D9-AD3A-4BC4-8B47-28AAB2696409Q35853499-AEB727DA-1745-4D06-8EEE-A104F68CE51DQ35923163-F48BBA8B-EB4D-4F18-AF1D-F6AD16585C87Q35928528-ABC95AD6-0AAB-4D05-9B18-B866DE14EBB2Q36565904-9B864E74-77A8-4C8C-A4A1-14BA65B93E56Q36651926-068FF80B-E844-4A26-977C-D5D2ADEC302DQ36748314-0DE51C67-3731-4246-A763-42939FA0C5D2Q36825607-D3F96892-8864-4437-9616-6A0C59082A4EQ37427390-00B733F3-0FA0-432A-BBA7-EE3E6F992F41Q37483208-9496E7CE-23E1-4EB9-8FE0-8EC0DF09BB10Q37780680-A57CC996-E67E-4C99-B78F-FD5C9BBB61F6Q37877040-F99FE0AA-CA27-43C6-8B75-64852A274B23Q37894860-C5014D29-2014-4590-A228-6384458B96F8Q38827777-74BBB69A-5168-49AF-8DAF-731B79419662Q41791619-B4161003-ECBB-41F7-ABA8-4C5AE0AFA64CQ41858907-70F0F740-7FCF-4F1F-B3A1-724AC0053F43Q41894032-E6F502A9-0ABF-45C8-B982-E89E324920F4Q41949841-E7C9C1DA-ED9C-4162-A68E-831C2303681CQ43114289-B12F3715-2D87-4335-A927-F88A94E6021BQ47150931-88A969A6-08F5-4479-A0CA-7F775A44F395Q47718667-85B1F012-8E3C-400E-A4FA-E8AC6B20995CQ48044643-4C77B830-9B07-4DD5-84FE-9F436B032F62Q48092315-6E57CDD7-0892-4A8F-A19F-98F83BAC84A4
P2860
Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Caveolin-3 knockout mice show ...... nstability in skeletal muscle.
@en
Caveolin-3 knockout mice show ...... nstability in skeletal muscle.
@nl
type
label
Caveolin-3 knockout mice show ...... nstability in skeletal muscle.
@en
Caveolin-3 knockout mice show ...... nstability in skeletal muscle.
@nl
prefLabel
Caveolin-3 knockout mice show ...... nstability in skeletal muscle.
@en
Caveolin-3 knockout mice show ...... nstability in skeletal muscle.
@nl
P2093
P2860
P1476
Caveolin-3 knockout mice show ...... nstability in skeletal muscle.
@en
P2093
Alex W Cohen
Dawn L Brasaemle
Franco Capozza
Jason K Kim
Linda A Jelicks
Philipp E Scherer
So-Young Park
Terence M Williams
Terry P Combs
William Schubert
P2860
P304
P356
10.1152/AJPCELL.00489.2004
P577
2005-02-02T00:00:00Z